258 related articles for article (PubMed ID: 22727470)
1. Radiation oncology and medical physicists quality assurance in British Columbia Cancer Agency Provincial Prostate Brachytherapy Program.
Keyes M; Morris WJ; Spadinger I; Araujo C; Cheung A; Chng N; Crook J; Halperin R; Lapointe V; Miller S; Pai H; Pickles T
Brachytherapy; 2013; 12(4):343-55. PubMed ID: 22727470
[TBL] [Abstract][Full Text] [Related]
2. Quality assurance needs for modern image-based radiotherapy: recommendations from 2007 interorganizational symposium on "quality assurance of radiation therapy: challenges of advanced technology".
Williamson JF; Dunscombe PB; Sharpe MB; Thomadsen BR; Purdy JA; Deye JA
Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S2-12. PubMed ID: 18406928
[TBL] [Abstract][Full Text] [Related]
3. Impact of quality assurance rounds in a Canadian radiation therapy department.
Lefresne S; Olivotto IA; Joe H; Blood PA; Olson RA
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e117-21. PubMed ID: 23195781
[TBL] [Abstract][Full Text] [Related]
4. The American Brachytherapy Society prostate brachytherapy LDR/HDR simulation workshops: Hands-on, step-by-step training in the process of quality assurance.
Frank SJ; Mourtada F; Crook J; Orio PF; Stock RG; Petereit DG; Rossi PJ; Cox BW; Tang C; Kudchadker RJ; Bruno T; Ma J; Sanders J; Keyes M
Brachytherapy; 2020; 19(6):787-793. PubMed ID: 33132070
[TBL] [Abstract][Full Text] [Related]
5. Current brachytherapy quality assurance guidance: does it meet the challenges of emerging image-guided technologies?
Williamson JF
Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S18-22. PubMed ID: 18406923
[TBL] [Abstract][Full Text] [Related]
6. Quality assurance in radiation oncology in the United States.
Purdy JA; Perez CA
Rays; 1996; 21(4):505-40. PubMed ID: 9122438
[TBL] [Abstract][Full Text] [Related]
7. Quality assurance of radiotherapy in cancer treatment: toward improvement of patient safety and quality of care.
Ishikura S
Jpn J Clin Oncol; 2008 Nov; 38(11):723-9. PubMed ID: 18952706
[TBL] [Abstract][Full Text] [Related]
8. Quality assurance of HDR prostate plans: program implementation at a community hospital.
Rush JB; Thomas MD
Med Dosim; 2005; 30(4):243-8. PubMed ID: 16275567
[TBL] [Abstract][Full Text] [Related]
9. AAPM Task Group 128: quality assurance tests for prostate brachytherapy ultrasound systems.
Pfeiffer D; Sutlief S; Feng W; Pierce HM; Kofler J
Med Phys; 2008 Dec; 35(12):5471-89. PubMed ID: 19175107
[TBL] [Abstract][Full Text] [Related]
10. Establishing high-quality prostate brachytherapy using a phantom simulator training program.
Thaker NG; Kudchadker RJ; Swanson DA; Albert JM; Mahmood U; Pugh TJ; Boehling NS; Bruno TL; Prestidge BR; Crook JM; Cox BW; Potters L; Moran BJ; Keyes M; Kuban DA; Frank SJ
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):579-86. PubMed ID: 25151539
[TBL] [Abstract][Full Text] [Related]
11. IAEA support to medical physics in nuclear medicine.
Meghzifene A; Sgouros G
Semin Nucl Med; 2013 May; 43(3):181-7. PubMed ID: 23561455
[TBL] [Abstract][Full Text] [Related]
12. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.
Ho AY; Burri RJ; Cesaretti JA; Stone NN; Stock RG
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):16-22. PubMed ID: 19289266
[TBL] [Abstract][Full Text] [Related]
13. Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapy.
Raben A; Rusthoven KE; Sarkar A; Glick A; Benge B; Jacobs D; Raben D
Brachytherapy; 2009; 8(3):297-303. PubMed ID: 19213608
[TBL] [Abstract][Full Text] [Related]
14. Quality assurance for 3D conformal radiation therapy.
Purdy JA; Harms WB
Strahlenther Onkol; 1998 Oct; 174 Suppl 2():2-7. PubMed ID: 9810330
[TBL] [Abstract][Full Text] [Related]
15. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
[TBL] [Abstract][Full Text] [Related]
16. The 1999 patterns of care study of radiotherapy in localized prostate carcinoma: a comprehensive survey of prostate brachytherapy in the United States.
Lee WR; Moughan J; Owen JB; Zelefsky MJ
Cancer; 2003 Nov; 98(9):1987-94. PubMed ID: 14584083
[TBL] [Abstract][Full Text] [Related]
17. Internal audit of a comprehensive IMRT program for prostate cancer: a model for centers in developing countries?
Koh WY; Ren W; Mukherjee RK; Chung HT
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1447-54. PubMed ID: 19250761
[TBL] [Abstract][Full Text] [Related]
18. Technical Note: The design, construction, and evaluation of a liquid-based single phantom solution for TG128 brachytherapy ultrasound QA.
Leong B; Ostyn M; Oh S; Kim S
Med Phys; 2019 Feb; 46(2):1024-1029. PubMed ID: 30472737
[TBL] [Abstract][Full Text] [Related]
19. Outcomes following iodine-125 monotherapy for localized prostate cancer: the results of leeds 10-year single-center brachytherapy experience.
Henry AM; Al-Qaisieh B; Gould K; Bownes P; Smith J; Carey B; Bottomley D; Ash D
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):50-6. PubMed ID: 20005453
[TBL] [Abstract][Full Text] [Related]
20. The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy.
Buyyounouski MK; Horwitz EM; Uzzo RG; Price RA; McNeeley SW; Azizi D; Hanlon AL; Milestone BN; Pollack A
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1383-91. PubMed ID: 15275723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
